Research Alliance Corp III

Analyst research, target price, syndicate analytics, and valuation sections are included with an active subscription. View plans

Investment Snapshot

424B4 All Filings

Symbol

RACC

IPO Date (Actual)

2026-05-20

Offer Range

$10.00

Shares Offered

7.5M

Total Shares Post-IPO

16.6M

Market Cap

—

Target Price

$00.00

Implied Upside vs Midpoint

$00.00

Use of Proceeds

—

Price Chart

Historic Price Chart - RACC

DividendsSplits/Mergers

Valuation & Price Target

████████████████████

Business & Product Moat

████████████████████

Company Description (Source)

We are a newly organized blank check company incorporated on February 19, 2026, as a Cayman Islands exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, we are targeting companies in the drug development and commercialization, diagnostic and healthcare technology and service sectors where our management has extensive investment experience. We may pursue a transaction with a target that is affiliated with RA Capital Management, our sponsor, directors or members of our management team. We may pursue a transaction in which our shareholders immediately prior to the completion of our initial business combination would collectively own a minority interest in the post-business combination company. --- Our executive offices are located at 600 Fifth Avenue, 23rd Floor, New York, NY 10020. Our telephone number is +1 (617) 778 2500.

Competitor Set

████████████████████